- Home
- NRXP vs WEA Comparison
NRXP vs WEA Comparison
Compare NRXP & WEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRXP | WEA |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.1M | 125.4M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | NRXP | WEA |
|---|---|---|
| Price | $2.45 | $9.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $38.75 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 63.5K |
| Earning Date | 11-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.87% |
| EPS Growth | ★ 69.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,225,000.00 | N/A |
| Revenue This Year | $357.94 | N/A |
| Revenue Next Year | $1,281.36 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.65 | $9.52 |
| 52 Week High | $5.06 | $11.42 |
Technical Indicators
Market Signals| Indicator | NRXP | WEA |
|---|---|---|
| Relative Strength Index (RSI) | 46.02 | 42.93 |
| Support Level | $1.68 | $9.55 |
| Resistance Level | $2.49 | $10.46 |
| Average True Range (ATR) | 0.22 | 0.09 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 50.00 | 45.59 |
Price Performance
Historical ComparisonAbout NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About WEA Western Asset Bond Fund Share of Beneficial Interest
Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The fund invests in bonds of companies operating in different sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.